Sight Sciences Stock Investor Sentiment

SGHT Stock  USD 3.98  0.03  0.75%   
Slightly above 76 percent of Sight Sciences' private investors are selling. The analysis of overall sentiment of trading Sight Sciences stock suggests that a fairly large number of investors are terrified at this time. Sight Sciences' investing sentiment can be driven by a variety of factors including economic data, Sight Sciences' earnings reports, geopolitical events, and overall market trends.
  

Sight Sciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Sight Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a month ago at news.google.com         
Insider Selling Sight Sciences, Inc. CTO Sells 3,167 Shares of Stock - MarketBeat
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 3167 shares by Badawi David of Sight Sciences at 5.986 subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Disposition of 3403 shares by Sam Park of Sight Sciences at 6.08 subject to Rule 16b-3
Macroaxis News
over a month ago at finance.yahoo.com         
Institutional investors own a significant stake of 34 percent in Sight Sciences, Inc.
Yahoo News
over a month ago at news.google.com         
Noridian final LCD positive for Sight Sciences, says Lake Street - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
Sight Sciences gains Medicare coverage for eye surgery tech - Investing.com India
Google News at Macroaxis
over two months ago at news.google.com         
Investment Report - Stock Traders Daily
Google News at Macroaxis
over two months ago at www.macroaxis.com         
Acquisition by Jeremy Hayden of 12000 shares of Sight Sciences subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
Lake Street Initiates Coverage of Sight Sciences with Buy Recommendation - Nasdaq
Google News at Macroaxis
over three months ago at globenewswire.com         
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
Macroaxis News: globenewswire.com
over three months ago at news.google.com         
Vanguard Group Inc. Purchases 81,768 Shares of Sight Sciences, Inc. - Defense World
Google News at Macroaxis
over three months ago at simplywall.st         
Why Were Not Concerned Yet About Sight Sciences, Inc.s 26 percent Share Price Plunge
Simply Wall St News at Macroaxis
over three months ago at news.google.com         
Sight Sciences, Inc. Receives Average Rating of Hold from Brokerages - MarketBeat
Google News at Macroaxis
over three months ago at insidermonkey.com         
Acquisition by Alison Bauerlein of 103000 shares of Sight Sciences subject to Rule 16b-3
insidermonkey News
over three months ago at insidermonkey.com         
Sight Sciences, Inc. Q2 2024 Earnings Call Transcript
insidermonkey News
Far too much social signal, news, headlines, and media speculation about Sight Sciences that are available to investors today. That information is available publicly through Sight media outlets and privately through word of mouth or via Sight internal channels. However, regardless of the origin, that massive amount of Sight data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sight Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sight Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sight Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sight Sciences alpha.

Sight Sciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Jeremy Hayden of 12000 shares of Sight Sciences subject to Rule 16b-3
09/16/2024
2
Disposition of 3403 shares by Sam Park of Sight Sciences at 6.08 subject to Rule 16b-3
10/01/2024
3
Disposition of 3167 shares by Badawi David of Sight Sciences at 5.986 subject to Rule 16b-3
10/02/2024
4
Sight Sciences CFO sells over 61k in company stock
10/04/2024
5
Disposition of 20734 shares by Matthew Link of Sight Sciences at 5.905 subject to Rule 16b-3
10/16/2024
6
Disposition of 21831 shares by Matthew Link of Sight Sciences at 5.609 subject to Rule 16b-3
10/21/2024
7
KCK LTD.s Strategic Reduction in NeuroPace Inc Shares
10/22/2024
8
Acquisition by Sam Park of 6000 shares of Sight Sciences at 1.96 subject to Rule 16b-3
10/25/2024
9
Insider Trading
11/04/2024
10
Sight Sciences Inc Q3 2024 Earnings Report Preview What To Expect
11/06/2024
11
Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance
11/07/2024
12
Sight Sciences Inc Q3 2024 Earnings Call Highlights Navigating Challenges with ...
11/08/2024
13
Acquisition by Manohar Raheja of 96000 shares of Sight Sciences at 4.59 subject to Rule 16b-3
11/12/2024
14
Sight Sciences, Inc. Stocks Pounded By 26 percent But Not Lagging Industry On Growth Or Pricing
11/13/2024
15
Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference
11/19/2024
16
Disposition of 551802 shares by Encrantz Staffan of Sight Sciences at 3.73 subject to Rule 16b-3
11/21/2024
17
Sight sciences EVP Manohar Raheja acquires 7,400 in stock
11/22/2024
18
Disposition of 2891 shares by Jesse Selnick of Sight Sciences at 12.379 subject to Rule 16b-3
11/25/2024

Additional Tools for Sight Stock Analysis

When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.